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ABSTRACT
In the classical model the energy requirements during neuronal activation are provided by the
delivery of additional glucose directly into the extracellular compartment that results from the
increase in local cerebral blood flow (rCBF). The present review proposes that astrocytes play a key
role in the response to neuronal activation. Arginine for the synthesis of NO, which has a major role
in the increase in rCBF, is released from astrocytes in response to stimulation of astrocytic
glutamate receptors. The increased delivery of glucose by the blood stream enters astrocytes,
where some of it is converted to glycogen. During neuronal activation there is a decrease in
extracellular glucose owing to increased utilization followed by a delayed increase; this results from
stimulation of astrocytic b-adrenergic receptors, which leads to a breakdown of glycogen and the
export of glucose.
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The brain, which makes up 2% of the body weight,
receives 15% of the cardiac output (Sokoloff 1960).
The role of the cerebral blood supply is the delivery to
the brain of metabolic substrates for the production of
energy and the removal of waste products. As there are
no energy reserves, a constant supply of oxygen and
glucose, the main metabolic substrates, is required and
any interruption of the blood supply rapidly produces
profound and irreversible changes of brain function
(Scheinberg & Joyne 1952, Choi 1990). An increase in
neuronal activity is accompanied by an increase in en-
ergy requirement. There has been much recent research
on the mechanisms for the provision of this additional
energy.
In this review the hypothesis proposed is that glu-
cose from the blood is not delivered directly to the
extracellular environment of the neurones but enters
the astrocytes from which its release is regulated by the
activation of noradrenergic b-receptors.
The brain is contained in a bony cranium and ce-
rebral tissue, cerebrospinal fluid and blood are incom-
pressible; the volume of the cerebral circulation is
therefore kept constant. However, global blood flow
can be increased by an increase in the velocity of flow
and local cerebral blood flow can be increased by a
process of redistribution, leading to a local increase in
both volume and velocity of flow in selected areas of
the brain.
The idea that cerebral blood flow varies with
brain activity was suggested towards the end of the
last century (Raichle 1998) but Roy & Sherrington
(1890) were the first to carry out experimental
investigations.
Localized blood flow is controlled by the state of
constriction of the small arterioles, which regulates the
distribution of blood to a capillary bed. Arteriolar
constriction is brought about by contraction of my-
ocytes which in turn depends on intracellular calcium
[Ca2+]i. Membrane potential of smooth muscle cells is a
major determinant of cytosolic [Ca2+]i and thus vas-
cular tone. Potassium channels play an important role
in the control of smooth muscle membrane potential.
However, some vasoactive agents can produce con-
traction or relaxation of cerebral blood vessels without
a change in membrane potential.
Much of the study of the control of cerebral blood
vessels has been carried out in vitro, either using the
patch clamp technique on isolated myocytes, to
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investigate the role of ion channels on membrane
potential, or the measurement of membrane potential
in intact but isolated vascular rings or segments. Such
studies have demonstrated the presence of four types
of K+ channels. The characteristics of these K+ chan-
nels and their role in the regulation of cerebral vascular
tone have been reviewed by Faraci & Sobey (1998). The
vasoactive stimuli which regulate these K+ channels
include nitric oxide (NO), cAMP, K+ ions; to these has
recently been added epoxyeicosatrienic acid (EET), a
product of Cytochrome P450 metabolism of arachi-
donic acid. NO can produce relaxation by either soluble
cGMP-dependent or soluble cGMP-independent
mechanisms. All these vasoactive mechanisms can be
activated by a wide variety of transmitters, metabolites
and drugs.
In order to determine the functional importance of
these mechanisms, experiments have been carried out
in vivo: where the changes in cerebral blood flow, that
result from the application of drugs which activate or
inhibit these various mechanisms are monitored. The
presence of multiple cell types makes it difficult to dis-
tinguish direct from indirect effects in these experiments.
Both hypoxia and hypercapnia lead to an increase in
cerebral blood flow and there have been numerous
studies of the factors which control cerebral blood flow
during these two conditions. Hypoxia and hypercapnia
are relatively easy to manipulate and produce changes in
blood flow. The increase of local cerebral blood flow
during neuronal activation, called functional hype-
raemia, is much more difficult to investigate. Whereas
hypoxia and hypercapnia cause changes in global
cerebral blood flow, whose duration is determined by
the time course of the changes in respiratory gases,
functional hyperaemia is triggered by a localized
increase in neuronal activity, which is usually short-lived
and produces very localized changes in cerebral blood
flow. These require techniques for measurement of
regional cerebral blood flow.
REGIONAL CEREBRAL BLOOD FLOW
(rCBF)
A widely used model of changes in rCBF in response to
neuronal activation by a physiological stimulus is the
rodent whisker barrel cortex. This has the advantage
that the whisker barrel cortex accounts for 20% of the
somatosensory area I in rodents and each sinus hair is
represented by a column of cortical cells supplied by
one penetrating artery (Welker 1971). The changes in
rCBF following whisker stimulation have been inves-
tigated with a wide variety of techniques, which include
the use of radioactive and volatile tracers, Doppler
flowmetry and videomicroscopy (Woolsey et al. 1996).
Although these methods vary in their spatial and tem-
poral resolution, they all show an increase in rCBF in
the activated region of the cortex and some methods
show a decrease in the neighbouring non-activated
cortical region. For an accurate determination of the
time course of the change in rCBF laser–Doppler
flowmetry (LDF) is one of the most useful techniques
as it gives a continuous record and has a time resolution
of 200 ms. Using this technique the rCBF increase
produced by whisker stimulation shows an initial peak
within 2–3 s after onset of stimulation, a sustained
plateau throughout the 60-s period of stimulation and a
return to near baseline level within 2–3 s after the end
of stimulation (Lindauer et al. 1993). This rapid time
course has to be taken into consideration in any pro-
posed mechanism for the increase in rCBF during
neuronal activation.
Astrocytes
Other important considerations are the anatomical re-
lationships of the small cerebral vessels. Astrocytes are
the most predominant type of glial cells in the CNS and
constitute over 50% of the cell mass in the brain. They
have an important role in a variety of brain functions
and their morphological relationship to both neurones
and cerebral blood vessels is therefore of considerable
importance.
Astrocytes, coupled by gap junctions, form a net-
work through which ions and small molecules can
move freely (Gutnick et al. 1981). Evidence from pri-
mary cortical cultures has demonstrated rapid com-
munication between neurones and astrocytes (Murphy
et al. 1993, Nedergaard 1994), attributed to the exis-
tence of gap junctions between neurones and astrocytes
by some (Nedergaard 1994) although denied by others
(Murphy et al. 1993). Ultrastructural studies have shown
that astrocytes contain glycogen granules, their endfeet
ensheath parenchymal microvessels and they also send
processes which surround synaptic complexes. (Peters
et al. 1991). More recent electron microscopic studies
have shown that the continuity of the atsrocytic endfeet
surrounding the cerebral vessels is interrupted by nor-
adrenergic nerve terminals (Papsapalas & Papadopou-
los 1996). Immunostaining has revealed that endothelial
cells carrying GLUT1 glucose transporters are envel-
oped by rosette-shaped endfeet derived from one or
more astrocytes. (Kacem et al. 1998). The astrocytic gap
junctions can be identified either by morphological
criteria or with anti-Connexin43 antibodies. Immuno-
cytochemical staining reveals a honeycomb meshwork
of astrocytic endfeet surrounding small blood vessels.
The gap junctions between the astrocytic endfeet allow
the passage not only of ions but also metabolic
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substrates such as glucose and lactate (Giaume et al. 1997)
and may act as a diffusion barrier between the blood
vascular system and the extracellular compartment.
Neurochemical changes
Neuronal activation by the application of physiological
stimuli leads to a number of changes in the extracellular
compartment which are potential mechanisms for the
regulation of rCBF.
One of the earliest changes is a rise in [K+]e. The use
of ion-selective electrodes has shown that repetitive
electrical nerve stimulation at 10–100 Hz elicits
increases in [K+]e of 2.0–3.5 mM (Sykova et al. 1992).
As glutamate is the main excitatory transmitter, acti-
vation of a brain area will involve the release of gluta-
mate. The use of microdialysis has shown that neuronal
activation by application of physiological stimuli, such as
induced grooming, is followed by a rise in the extracel-
lular concentration of glutamate (Miele et al. 1996).
Overflow from the synaptic cleft of glutamate from the
vesicular store is one possible source for the rise in
extracellular glutamate. However, the demonstration
that such glutamate release is not abolished by local
infusion of TTX or Ca2+ channel blockers suggests that
there must be other mechanisms and sources of
glutamate release, astrocytes being one possible source
(Miele et al. 1996, Timmerman & Westerink 1997).
Increase in rCBF during neuronal activity
Rise in [K+]e
The rise in [K+]e has long been regarded as the agent
responsible for the increase in rCBF following neuronal
activation. The efflux of K+ during electrical activity of
neurones would produce a very much greater increase
in [K+]e than the observed increase of 2.5–3 mM, if it
were not for clearance mechanisms. Astrocytes have an
important role in spatial buffering (Gardner-Medwin
1983). Their high K+ permeability allows them to
reduce local accumulation by uptake of K+, which is
then distributed through the electrically coupled
network of astrocytes to other parts of the extracellular
space, for eventual return to the neurones. This redis-
tribution involves a number of ion channels as well as
the Na+/K+ pump (Amedee et al. 1997).
The high density of potassium channels in astrocytic
endfeet (Newman 1986) has raised the possibility that
release of K+ from these endfeet could regulate cere-
bral blood flow. The results of computer simulations of
K+ dynamics in the brain indicate that the release of K+
from astrocytic endfeet raises perivascular K+ concen-
tration much more rapidly and to higher levels than
does diffusion of K+ through the extracellular space
(Paulson & Newman 1987). Experiments with isolated
cerebral arterioles show that K+ dilates these vessels by
a mechanism which, blocked by barium or caesium, is
caused by the opening of K+ channels, the most likely
being the inwardly rectifying K+ channels (Quayle et al.
1993). In slices of guinea-pig olfactory cortex, stimu-
lation of the olfactory tract leads to an uptake of K+
into astrocytes following the stimulation-induced rise in
[K+]e; this uptake is blocked in the presence of Ba
2+
(Ballanyi et al. 1987).
Attempts have been made to assess the importance
of these mechanisms in vivo. Local surface electrical
stimulation of the cortex causes an increase in rCBF, in
[K+]e and in astroglial [K
+]. During Ba2+ superfusion
the stimulated increase in astroglial [K+] is diminished
but the stimulated increase in rCBF and [K+]e is slightly
enhanced (Kraig & Iadecola 1989).
Stimulation of the fastigial nucleus of the cerebellum
increases cortical CBF by about 200% with no change
in local metabolism (Nakai et al. 1983). When changes
in [K+]e were monitored during such stimulation,
increases were found to range from 0.5–2.9 mM and
had a very much more restricted distribution than the
increase in CBF. In order to see whether changes in
[K]e could account for the increase in CBF, the cortex
was superfused with a 20 mM K solution: this produced
an increase in CBF of only 17  2%. (Iadecola & Kraig
1991).
These findings argue against a role for [K]e in the
stimulated increase in rCBF.
NO
An alternative mechanism for the increase in rCBF is
the mediation by NO whose release is triggered by the
action of glutamate. Of the three forms of nitric oxide
synthetase (NOS), neuronal NOS (nNOS) is constitu-
tively expressed in neurones and is activated by Ca2+/
calmodulin. Immunocytochemical studies have shown
that nNOS in the cerebral cortex is found in a heter-
ogeneous morphological group of neurones, which
make up no more than 0.2–0.3% of the total neuronal
population. One of the chemical characteristics of
these nNOS containing neurones is the high degree of
co-localization with GABA and the peptides somato-
statin and NPY (Estrada & DeFelipe 1998).
In vivo NO is a powerful vasodilator (Marshall et al.
1988) and regulates resting cerebral blood flow (Faraci
1990, Rosenblum et al. 1990). Stimulation of gluta-
matergic NMDA receptors causes release of NO,
dilatation of cerebral blood vessels (Faraci & Breese
1993) and an increase in cerebral blood flow (Yang &
Chang 1998). nNOS, mainly found in neurones,
requires arginine, which is localized in astrocytes.
Arginine is released from brain slices and astrocytic
cultures by glutamate acting on non-NMDA ionotropic
glutamate receptors (Grima et al. 1997).
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Administration of Nw-substituted arginine ana-
logues, which inhibit NOS stereospecifically and com-
petitively, decrease resting cerebral arterial and
arteriolar diameter (Faraci 1990, Rosenblum et al. 1990,
Faraci & Breese 1993) and resting cerebral blood flow
(Tanaka et al. 1991, Iadecola 1992, Dirnagl et al. 1993).
Electrical stimulation of the rat sciatic nerve (North-
ington et al. 1992), or vibrissal stimulation (Amedee
et al. 1997), produce an increase in cerebral blood flow
in the somatosensory cortex, which is abolished by
NOS inhibitors. NOS inhibitors have no effect on basal
or stimulated cerebral metabolism (Cholet et al. 1997).
The use of selective glutamatergic receptor antagonists
has demonstrated the critical role of astrocytes, because
the release of arginine from astrocytes controls neuro-
nal NO synthesis and release (Grima et al. 1998).
It appears that the increase in CBF produced by
infusion of K+ is also mediated by NO. Topical
superfusion of 20 mM K+ in artificial CSF induces an
elevation in rCBF which is abolished when a NOS
inhibitor is added to the perfusion medium (Dreier et al.
1995).
These results suggest that NO may be the agent
responsible for the increase in rCBF during neuronal
activation. The parallel fibre system in the cerebellar
vermis of anaesthetized rats has been used to test this
hypothesis. Electrical stimulation of the parallel fibres
produces an increase in local blood flow; this is reduced
by the NOS inhibitor L-NNA, as well as methylene
blue, which eliminates NO and inhibits cGMP-medi-
ated responses (Iadecola et al. 1995). The reduction of
rCBF is around 50% and never complete. Measurement
of blood vessel diameter shows that increases in cere-
bellar blood flow are associated with increases in vas-
cular diameter in the activated area. The vasodilation is
greatest in smaller arterioles; however, parallel fibre
stimulation also increases the vascular diameter in larger
arterioles located in adjacent folia. These changes occur
in areas outside the increase in neuronal activity as no
field potentials are recorded in the area where these
upstream vessels are located (Iadecola et al. 1997).
These findings suggest that neuronal activation,
which involves release of glutamate, activates nNOS
mainly via NMDA receptors and simultaneously
induces the release of arginine from glial cells upon
activation of glial ionotropic non-NMDA receptors.
Thus the increase in rCBF during neuronal activation
depends on the concurrent occurrence of two signals:
one for the activation of the enzyme and the other for
the supply of substrate (Grima et al. 1998).
Adenosine
The fact that inhibition of NOS causes only a 50%
reduction in the increase in rCBF during neuronal
activation suggests the involvement of an additional
mechanism. Such a mechanism has not yet been iden-
tified, but there is some evidence that adenosine may
have a role. The increase in rCBF in response to elec-
trical stimulation of cerebellar parallel fibres is blocked
by the adenosine receptor antagonist 8-sulphophenyl-
theophylline (8-SPT). Co-application of 8-SPT and of
the NOS inhibitor nitro-L-arginine (L-NA) produces an
additive effect (Li & Iadecola 1994). The activation of
cerebellar Purkinje cells by two afferent systems, the
parallel fibres and the climbing fibres, reveals complex
activity-dependent increases in CBF. Whereas the blood
flow increases stimulated by both afferent pathways are
partially mediated by NO, adenosine contributes to the
blood flow increase in response to stimulation of the
climbing fibre but not the parallel fibre input (Akgoren
et al. 1997). The increase in cortical blood flow by rat
whisker stimulation is also inhibited by both NOS
inhibition and adenosine receptor antagonists. How-
ever, the finding that superfusion of a NOS inhibitor
attenuates the blood flow response to application of
adenosine, led to the conclusion that both adenosine
and NO are involved in coupling of cerebral blood flow
to neuronal activation and that there is an interaction
between the vasodilator pathways of adenosine and NO
(Dirnagl et al. 1994). Sciatic nerve stimulation increases
rCBF in the somatosensory cortex but does not cause
release of adenosine. Infusion of 8-SPT decreases basal
cerebral blood flow but does not block the stimulated
increase in rCBF (Pellerin et al. 1997).
EET
Recently an alternative mechanism has been proposed
for the increase in rCBF during neuronal activation
which also involves the action of glutamate on glial
cells. In addition to ionotropic glutamate receptors
astrocytes also have metabotropic glutamate receptors.
The activation of these receptors leads to a release of
Ca2+ from intracellular stores and the release of
arachidonic acid from membrane lipids by activation
of phospholipase C, phospholipase A2 and diacylglyc-
erol. The enzyme cytochrome P450 is also localized in
astrocytes. This enzyme catalyses the formation of
epoxyeicosatrienoic acids (EETs) which are powerful
vasodilators. The hypothesis is proposed that glutamate
release leads to the release of EETs from the astrocytic
endfeet which envelop the cerebral blood vessels. The
evidence for this hypothesis is based on the inhibition
of the increase in rCBF during neuronal activation by
inhibitors of P450 (Harder et al. 1998).
ROLE OF INCREASED rCBF.
The role of the raised rCBF during neuronal activation
is to augment the delivery of oxygen and glucose to
cope with the greater energy demands. Oxygen is freely
diffusible and therefore the rate of oxygen delivery is
278 Ó 1999 Scandinavian Physiological Society
Noradrenaline and brain glucose  M Fillenz et al. Acta Physiol Scand 1999, 167, 275–284
equivalent to the rate of flow of oxyhaemoglobin
through the brain region. The tissue concentration of
oxygen estimated electrochemically is a measure of the
balance between oxygen delivery and oxygen utilization.
The fact that during neuronal activation the increase in
rCBF measured by the hydrogen clearance technique is
paralleled by a similar increase in tissue oxygen (Lowry
et al. 1997) suggests that there is only a very small
increase in oxygen consumption. This has been con-
firmed using both fMRI and optical imaging (Raichle
1998). Quantitative changes in oxygen consumption in
rats during neuronal activation have been calculated
from measurements of changes in CBF and arterio-
venous differences in oxygen. These have shown a 60%
increase in CBF but only a 16% increase in oxygen
consumption. As these were derived from global rather
than local changes, the disparity in CBF increase and
oxygen consumption in the activated area of the brain is
likely to be even greater (Madsen et al. 1998).
Uptake of glucose
Studies similar to those for the uptake of oxygen have
been carried out for the uptake and utilization of glu-
cose. Sokoloff devised a method which uses [14C]de-
oxyglucose, an analogue of glucose, which is not
metabolized by phosphohexoisomerase and is therefore
trapped in the tissue either as [14C]deoxyglucose-6-
phosphate or as [14C]deoxyglycogen. Local tissue con-
centrations of 14C are determined by quantitative
densitometric analysis of autoradiographs of brain
sections. From this, using a lumped constant which
includes the various kinetic parameters, a figure is cal-
culated which has been claimed to represent the re-
gional cerebral glucose utilization (Sokoloff et al. 1977).
The technique takes 45 min during which a steady state
is assumed and has been criticized on a number of
other points (Sacks & Fleischer 1983). Furthermore, as
2-deoxyglucose (2DG) cannot enter the metabolic cy-
cle, its use clearly can only measure uptake and not
metabolism. An alternative is the use of radiolabelled
glucose, provided there is full retention of the label in
the brain during the experiment. A comparison of
[14C]glucose labelled in positions 1, 2 and 6 showed
that for measurement of total glucose utilization [6-14C]
glucose is the labelled substrate of choice, but when
measurement of energy metabolism is required use of
[1-14C] glucose avoids inclusion of the non-energy-
yielding pentose phosphate pathway (Hawkins et al.
1985). Both the uptake of [14C]2DG and local cerebral
glucose utilization calculated from [6-14C] glucose are
closely correlated with rCBF measured with iodo-
[14C]antipyrine (Hawkins et al. 1985, Sokoloff 1989).
Whereas oxygen diffuses freely throughout the
brain, the compartment into which glucose is taken up
from the blood is more difficult to determine. With the
2DG method radioactivity was found to be high in the
neurophil, which contains the synaptic complexes
(Sokoloff 1989). This was initially taken to mean that
glucose was taken up into nerve terminals, which have a
high energy requirement. Tsacopoulos using a prepa-
ration of retinal photoreceptors and Mu¨ller cells,
showed that glucose in this preparation is taken up by
the glial cells, which then export both lactate and ala-
nine, which are subsequently taken up into the photo-
receptors and oxidized (Poitry Yamate & Tsacopoulos
1991, Poitry Yamate et al. 1995).
Under basal conditions there is close coupling
between rCBF and oxygen utilization and the energy
requirements of the brain are thought to be provided by
the oxidation of glucose resulting in an oxygen/glucose
uptake ration of 6:1 (Madsen et al. 1998). Fox and
Raichle in 1986 first reported a regional uncoupling of
CBF and oxygen utilization during neuronal activation,
induced by somatosensory stimulation in human sub-
jects using PET (Fox & Raichle 1986). This was con-
firmed in a study of human visual cortex during visual
stimulation, where glucose utilization and CBF
increased by 51 and 50% respectively, whereas oxygen
utilization increased by only 5%. (Fox et al. 1988). A
similar disparity of oxygen and glucose uptake during
neuronal activation was found in the rat (Madsen et al.
1998). The decrease in the ratio of oxygen/glucose
uptake during activation was less in the rat, where
global arterio-venous differences were measured, than
in the human study using PET, where local changes
were monitored.
The use of radiolabelled glucose or its analogue
2DG, cannot identify the compartment which glucose
enters, when taken up from the blood. With microdi-
alysis and implanted sensors, changes in the extracel-
lular compartment of the brain are monitored. In
microdialysis experiments in the rat striatum, stimuli
which produce a motor response were found to cause a
decrease in dialysate glucose during the period when
rCBF was increased (Fray et al. 1996). Implanted oxy-
gen electrodes and glucose sensors show an even more
striking dissociation of the changes in extracellular
oxygen and glucose: their concentrations in the extra-
cellular compartment are found to move in opposite
directions during the increase in rCBF which accom-
panies neuronal activation (Lowry & Fillenz 1997). The
implication of these findings is that during the increase
in rCBF the supply of oxygen greatly exceeds its utili-
zation, while little of the glucose taken up enters the
extracellular compartment directly.
In an effort to examine the effect of a reduction in
neuronal activation on rCBF, and oxygen and glucose
uptake, rats were given systemic administration of
anaesthetics. These experiments showed a dissociation
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between the changes in rCBF, tissue oxygen and
glucose concentration in the extracellular compart-
ment: the extracellular glucose concentration was
reduced in all cases but the rCBF and oxygen con-
centration decreased with some anaesthetics and
increased with others (Fillenz & Lowry 1998a and
unpublished). This lends further support to the
hypothesis that in contrast to oxygen, there is no
simple relationship between CBF and extracellular
concentration of glucose.
Glucose that enters the brain, in addition to being
oxidized to CO2 and H2O, can be converted to lactate,
to intermediates of the Krebs cycle, to amino acids or
to glycogen.
Glycogen
Glycogen in the brain is localized to astrocytes. The fact
that in the presence of normal levels of blood glucose it
has a rapid turnover suggests that it plays a role in
normal brain metabolism rather than serving as an
energy store to be used when glucose supply fails. The
finding that sensory stimulation causes a breakdown of
glycogen (Swanson et al. 1992), whereas during anaes-
thesia and hibernation glycogen stores in the brain in-
crease (Swanson 1992), provides evidence for the
coupling of astrocytic glycogen metabolism to neuronal
activity.
In astrocytic cultures various neurotransmitters,
including peptides, were found to produce break-
down of glycogen (Cambray Deakin et al. 1988,
Subbarao & Hertz 1990, Magistretti et al. 1993,
Zhang et al. 1993). The effector mechanisms of the
activated receptors was either a rise in cAMP or
[Ca2+]i. Among the neurotransmitters producing gly-
cogen breakdown is noradrenaline acting on b-adre-
noceptors (Sorg & Magistretti 1991, Hertz & Peng
1992). Furthermore there is evidence that b-adreno-
ceptors are localized mainly on astrocytes (McCarthy
1988, Stone & Ariano 1989, Aoki & Pickel 1992).
Although Stone was the first to suggest that the
function of the noradrenergic action on glia may be
the release of glucose for neuronal energy production
(Stone & Ariano 1989), in cultured astrocytes glyco-
genolysis always results in the release of lactate not
glucose (Dringen et al. 1993).
There is extensive evidence that neuronal activation
leads to an increase in lactate in the brain (Fox et al.
1988, Fray et al. 1996) and that lactate can be used as a
metabolic substrate by neurones (Schurr et al. 1988,
1997a, b). However, the stimulated release of lactate
both in cultured astrocytes (Pellerin & Magistretti 1994)
and in vivo (Fray et al. 1996, Demestre et al. 1997)
appears to be dependent on glutamate uptake as it is
blocked by glutamate uptake blockers.
THE ROLE OF NORADRENALINE
Evidence from a number of sources suggests that
noradrenaline has a role in brain metabolism. A uni-
lateral lesion of the locus coeruleus removes the nor-
adrenergic innervation of the cerebral cortex on the
lesioned side. Electrical stimulation results in a much
reduced increase in cerebral oxidative metabolism on
the lesioned compared with the control side (Harik
et al. 1979, LaManna et al. 1981). Furthermore while
such a lesion has no effect on the concentration of
cAMP and glycogen in the unstimulated brain, during
seizures and ischaemia there is a decrease in glycogen
and an increase in cAMP on the unlesioned but not on
the lesioned side (Harik et al. 1982). A more direct
demonstration of the link between neuronal activity
and glycogen turnover was the finding that tactile
stimulation of the rat face and vibrissae accelerates the
utilization of labelled glycogen in brain regions known
to receive sensory input from face and vibrissae
(Swanson et al. 1992).
In microdialysis experiments infusion of both the
b-adrenoceptor agonist isoprenaline and cAMP causes
an increase in dialysate glucose. In response to physi-
ological neuronal activation the decrease in glucose
which accompanies the increase in rCBF during the
stimulation is followed by a delayed increase in glucose.
This delayed increase in glucose is blocked by the local
infusion of the b-adrenoceptor antagonist propranolol
(Fray et al. 1996). As adrenergic receptors are found on
cerebral microvessels (Harik et al. 1981), these effects
could be mediated by effects on the cerebral circulation.
However, the increase in glucose occurs after the rCBF
has returned to the control value. More significantly
local infusion of propranolol has no effect on the in-
crease in rCBF that accompanies neuronal activation
(Fray et al. 1996).
It is important to emphasize that dialysate glucose,
which reflects changes in extracellular glucose concen-
tration, represents the balance between supply and
utilisation. The extracellular glucose concentration
during basal conditions is 350 lM (Fray et al. 1997,
Lowry et al. 1998b). Local infusion of veratridine,
which opens Na+ channels and so stimulates Na+/K+
ATPase and energy consumption, is accompanied by a
dramatic decrease in extracellular glucose (Fray et al.
1997). Extracellular glucose is also reduced during
hypoxia (Lowry et al. 1998a) and, as mentioned above,
during neuronal activation (Lowry & Fillenz 1997) and
in response to anaesthetics (Fillenz & Lowry 1998a).
Extracellular glucose is increased following physiological
stimulation (Fray et al. 1996, Lowry & Fillenz 1997) and
during hyperoxia (Lowry et al. 1998a). The fact that
local infusion of propranolol blocks some increases but
not others suggests that it may serve to distinguish
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between a rise caused by increased release and one by
decreased utilisation. Propranolol blocks the increase in
glucose following neuronal activation but not that
accompanying hyperoxia (Fig. 1); this suggests that the
former represents a noradrenaline-dependent increase
in delivery of glucose while the latter is due to a
noradrenaline-independent decrease in utilization (Fill-
enz & Lowry 1998b).
Proposed hypothesis
In conclusion Fig. 2 represents the hypothesis put
forward in this paper. It is proposed that astrocytes play
a crucial role both in the increase in rCBF and the
increased supply of glucose during neuronal activation.
Different receptors on astrocytes, activated by different
neurotransmitters, are responsible for these two func-
tions. Stimulation of astrocytic ampa/kainate receptors
Figure 1 Changes in extracellular glucose
measured with an enzyme-based sensor
implanted in the rat striatum. The application
of a 5 min tail pinch produces a decrease
followed by an increase in glucose; exposure to
a 3 min oxygen/air mixture causes an increase
in glucose. Local infusion of 50 lM
propranolol, a b-adrenoceptor antagonist,
abolishes the increase in glucose following tail
pinch but has no effect on the increase owing
to hyperoxia. For futher details see Fillenz &
Lowry (1998a, b).
Figure 2 A schematic representation of the
role of astrocytes in the activity-dependent
increase in rCBF and glucose.
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by glutamate leads to the release of arginine for the
synthesis of NO, which is responsible for the increase
in rCBF. The increase in glucose delivery by the blood,
that accompanies the increase in rCBF, is taken up by
atsrocytes, where some of it is converted to glycogen.
Noradrenaline, acting on astrocytic b-adrenoceptors,
causes the breakdown of glycogen to glucose, which
enters the extracellular compartment, from where it is
taken up by neurones.
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